首页 › 基金 › Ishara Investments LP › MREO
Ishara Investments LP 对 MREO 的持仓历史
MEREO BIOPHARMA GROUP FUNSPONSORED ADR 1 ADR REPS 5 ORD SHS · 医疗保健
Ishara Investments LP 在 Q2 2026 的 13F 申报中披露持有 MREO(MEREO BIOPHARMA GROUP FUNSPONSORED ADR 1 ADR REPS 5 ORD SHS)768,750 股,市值约 US$244K,约占其申报组合的 0.18%,在其申报持仓中市值排名第 40 位。 Ishara Investments LP 于 Q2 2026 首次申报该持仓。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
Ishara Investments LP 对 MREO 的持仓演变
Ishara Investments LP 于 Q2 2026 首次披露 MREO 持仓:768,750 股(约 US$244K)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2026 | 768.75K | $244.23K | 新进 |
关于 MREO 与 13F 数据
MREO(MEREO BIOPHARMA GROUP FUNSPONSORED ADR 1 ADR REPS 5 ORD SHS)属于医疗保健行业。我们追踪的基金中还有 5 只申报持有 MREO,申报仓位最大的包括:Defilade Capital Management, L.P. (US$2.4M), Newtyn Management, LLC (US$953K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MREO 的基金
- Defilade Capital Management, L.P. 7.56M 股 · $2.40M · Q2 2026
- Newtyn Management, LLC 3.00M 股 · $953.10K · Q2 2026
更多关于 Ishara Investments LP
常见问题
How long has Ishara Investments LP held MREO?
Ishara Investments LP has disclosed MREO holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Ishara Investments LP's current position in MREO?
As of Q2 2026, Ishara Investments LP holds 768.75K shares of MREO (MEREO BIOPHARMA GROUP FUNSPONSORED ADR 1 ADR REPS 5 ORD SHS), valued at $244.23K, representing 0.18% of its reported portfolio and ranking #40.
Has Ishara Investments LP been buying or selling MREO?
In the latest 13F filing (Q2 2026), Ishara Investments LP newly opened its position in MREO.
Which other funds hold MREO?
Other major institutional holders of MREO include Defilade Capital Management, L.P., Newtyn Management, LLC, among 5 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.